China Cord Blood Corp. (NYSE:CO)’s share price reached a new 52-week low on Wednesday . The company traded as low as $4.96 and last traded at $4.96, with a volume of 30,109 shares traded. The stock had previously closed at $5.04.

CO has been the topic of a number of recent analyst reports. Zacks Investment Research raised shares of China Cord Blood Corp. from a “sell” rating to a “hold” rating in a research note on Thursday, August 11th. TheStreet downgraded shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $7.00.

The firm has a market capitalization of $395.61 million and a P/E ratio of 26.28. The stock has a 50 day moving average of $5.39 and a 200-day moving average of $5.87.

China Cord Blood Corp. (NYSE:CO) last announced its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.03. The business earned $24.30 million during the quarter. On average, equities research analysts forecast that China Cord Blood Corp. will post $0.17 EPS for the current fiscal year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.